Back

Proteomics in low CVD risk black women living with HIV: H-ART to Heart Study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: HIV and cardiovascular disease (2) HIV and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Gavin Paul Raphael Manmathan

Victoria Heart, Melbourne (Australia)

7 More presentations in this session

Presentation thumbnail
HIV is associated with subtle impairments in left ventricular function: insights from a large prospective cohort study of well-treated people with HIV
Doctor A. Reimer Jensen (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Thrombus aspiration in people living with HIV- a night mare for interventionist
Associate Professor H. Nataraj Setty (Bangalore, IN)
Abstract Slides Video
Presentation thumbnail
Pericoronary adipose tissue computed tomography attenuation (PCAT) as a marker of premature CVD in asymptomatic people living with HIV (PLWH) without traditional risk factors: H-ART to heart study
Doctor T. Wardill (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
HIV and cardiovascular risk: should we use other targets for cholesterol control? Brazilian data compared to major studies
Mrs A. Murta (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
The effect of HIV seropositivity on inpatient outcomes in atrial tachyarrhythmias: a US population analysis
Doctor J. Folkes (Margate, GB)
Abstract Slides Video

Access the full session

Session thumbnail
HIV and cardiovascular disease (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Large-scale proteomic profiling reveals characteristic HIV-specific druggable protein signatures associated with incident heart failure
thumbnail
Congress Presentation
A novel plasma proteomic signature predicts 10-year incident heart failure risk among persons living with HIV
thumbnail
Congress Presentation
Cardiac biomarkers can detect and track subclinical HIV-associated myocardial disease in newly diagnosed people living with HIV

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources